Statins and Reduction of Oxidative Stress in the Aged Brain

Tomoko Kurata, Kentaro Deguchi, Shoko Deguchi, Yoshio Ikeda, Koji Abe

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

A strong relationship between metabolic syndromes such as hyperlipidemia or hyperglycemia and dementia has been suggested in many cell culture and animal studies. Both hypercholesterolemia and oxidative stress may be involved in the molecular mechanism underlying Alzheimer's disease (AD), and lipid peroxidation products such as 4-hydroxy-2-nonenal were actually elevated in the brains of AD patients. Meanwhile, hyperglycemia and insulin resistance also lead to a number of pathological processes, including oxidative stress, advanced glycation end products formation, and insulin-signaling impairment in the central nervous system. Statins, 3-hydroxy-3-methyl glutaryl coenzyme A reductase inhibitors currently in worldwide clinical use for treatment of hyperlipidemia, reduce levels of cortical amyloid β and oxidative stress with or without affecting cholesterol levels. As statins show various pleiotropic effects, they have high potential as a therapeutic approach to AD.

Original languageEnglish
Title of host publicationDiet and Nutrition in Dementia and Cognitive Decline
PublisherElsevier Inc.
Pages753-760
Number of pages8
ISBN (Print)9780124079397, 9780124078246
DOIs
Publication statusPublished - Nov 18 2014

Fingerprint

Hydroxymethylglutaryl-CoA Reductase Inhibitors
Alzheimer Disease
Oxidative Stress
Hyperlipidemias
Hyperglycemia
Brain
Advanced Glycosylation End Products
Brain Diseases
Pathologic Processes
Hypercholesterolemia
Amyloid
Lipid Peroxidation
Dementia
Insulin Resistance
Oxidoreductases
Central Nervous System
Cell Culture Techniques
Cholesterol
Insulin
Therapeutics

Keywords

  • Alzheimer's disease
  • Amyloid β
  • Metabolic syndrome
  • Oxidative stress
  • Phosphorylated tau
  • Statin

ASJC Scopus subject areas

  • Nursing(all)

Cite this

Kurata, T., Deguchi, K., Deguchi, S., Ikeda, Y., & Abe, K. (2014). Statins and Reduction of Oxidative Stress in the Aged Brain. In Diet and Nutrition in Dementia and Cognitive Decline (pp. 753-760). Elsevier Inc.. https://doi.org/10.1016/B978-0-12-407824-6.00069-0

Statins and Reduction of Oxidative Stress in the Aged Brain. / Kurata, Tomoko; Deguchi, Kentaro; Deguchi, Shoko; Ikeda, Yoshio; Abe, Koji.

Diet and Nutrition in Dementia and Cognitive Decline. Elsevier Inc., 2014. p. 753-760.

Research output: Chapter in Book/Report/Conference proceedingChapter

Kurata, T, Deguchi, K, Deguchi, S, Ikeda, Y & Abe, K 2014, Statins and Reduction of Oxidative Stress in the Aged Brain. in Diet and Nutrition in Dementia and Cognitive Decline. Elsevier Inc., pp. 753-760. https://doi.org/10.1016/B978-0-12-407824-6.00069-0
Kurata T, Deguchi K, Deguchi S, Ikeda Y, Abe K. Statins and Reduction of Oxidative Stress in the Aged Brain. In Diet and Nutrition in Dementia and Cognitive Decline. Elsevier Inc. 2014. p. 753-760 https://doi.org/10.1016/B978-0-12-407824-6.00069-0
Kurata, Tomoko ; Deguchi, Kentaro ; Deguchi, Shoko ; Ikeda, Yoshio ; Abe, Koji. / Statins and Reduction of Oxidative Stress in the Aged Brain. Diet and Nutrition in Dementia and Cognitive Decline. Elsevier Inc., 2014. pp. 753-760
@inbook{cb81b1e6bec44abb8de3469b36da848e,
title = "Statins and Reduction of Oxidative Stress in the Aged Brain",
abstract = "A strong relationship between metabolic syndromes such as hyperlipidemia or hyperglycemia and dementia has been suggested in many cell culture and animal studies. Both hypercholesterolemia and oxidative stress may be involved in the molecular mechanism underlying Alzheimer's disease (AD), and lipid peroxidation products such as 4-hydroxy-2-nonenal were actually elevated in the brains of AD patients. Meanwhile, hyperglycemia and insulin resistance also lead to a number of pathological processes, including oxidative stress, advanced glycation end products formation, and insulin-signaling impairment in the central nervous system. Statins, 3-hydroxy-3-methyl glutaryl coenzyme A reductase inhibitors currently in worldwide clinical use for treatment of hyperlipidemia, reduce levels of cortical amyloid β and oxidative stress with or without affecting cholesterol levels. As statins show various pleiotropic effects, they have high potential as a therapeutic approach to AD.",
keywords = "Alzheimer's disease, Amyloid β, Metabolic syndrome, Oxidative stress, Phosphorylated tau, Statin",
author = "Tomoko Kurata and Kentaro Deguchi and Shoko Deguchi and Yoshio Ikeda and Koji Abe",
year = "2014",
month = "11",
day = "18",
doi = "10.1016/B978-0-12-407824-6.00069-0",
language = "English",
isbn = "9780124079397",
pages = "753--760",
booktitle = "Diet and Nutrition in Dementia and Cognitive Decline",
publisher = "Elsevier Inc.",

}

TY - CHAP

T1 - Statins and Reduction of Oxidative Stress in the Aged Brain

AU - Kurata, Tomoko

AU - Deguchi, Kentaro

AU - Deguchi, Shoko

AU - Ikeda, Yoshio

AU - Abe, Koji

PY - 2014/11/18

Y1 - 2014/11/18

N2 - A strong relationship between metabolic syndromes such as hyperlipidemia or hyperglycemia and dementia has been suggested in many cell culture and animal studies. Both hypercholesterolemia and oxidative stress may be involved in the molecular mechanism underlying Alzheimer's disease (AD), and lipid peroxidation products such as 4-hydroxy-2-nonenal were actually elevated in the brains of AD patients. Meanwhile, hyperglycemia and insulin resistance also lead to a number of pathological processes, including oxidative stress, advanced glycation end products formation, and insulin-signaling impairment in the central nervous system. Statins, 3-hydroxy-3-methyl glutaryl coenzyme A reductase inhibitors currently in worldwide clinical use for treatment of hyperlipidemia, reduce levels of cortical amyloid β and oxidative stress with or without affecting cholesterol levels. As statins show various pleiotropic effects, they have high potential as a therapeutic approach to AD.

AB - A strong relationship between metabolic syndromes such as hyperlipidemia or hyperglycemia and dementia has been suggested in many cell culture and animal studies. Both hypercholesterolemia and oxidative stress may be involved in the molecular mechanism underlying Alzheimer's disease (AD), and lipid peroxidation products such as 4-hydroxy-2-nonenal were actually elevated in the brains of AD patients. Meanwhile, hyperglycemia and insulin resistance also lead to a number of pathological processes, including oxidative stress, advanced glycation end products formation, and insulin-signaling impairment in the central nervous system. Statins, 3-hydroxy-3-methyl glutaryl coenzyme A reductase inhibitors currently in worldwide clinical use for treatment of hyperlipidemia, reduce levels of cortical amyloid β and oxidative stress with or without affecting cholesterol levels. As statins show various pleiotropic effects, they have high potential as a therapeutic approach to AD.

KW - Alzheimer's disease

KW - Amyloid β

KW - Metabolic syndrome

KW - Oxidative stress

KW - Phosphorylated tau

KW - Statin

UR - http://www.scopus.com/inward/record.url?scp=84943259336&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84943259336&partnerID=8YFLogxK

U2 - 10.1016/B978-0-12-407824-6.00069-0

DO - 10.1016/B978-0-12-407824-6.00069-0

M3 - Chapter

AN - SCOPUS:84943259336

SN - 9780124079397

SN - 9780124078246

SP - 753

EP - 760

BT - Diet and Nutrition in Dementia and Cognitive Decline

PB - Elsevier Inc.

ER -